Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 740873-06-7, Prx-00023, Naluzotan (free base), Lq54e5b4ew, Chembl209821, Unii-lq54e5b4ew
Molecular Formula
C23H38N4O3S
Molecular Weight
450.6  g/mol
InChI Key
SPWZXWDPAWDKQE-UHFFFAOYSA-N
FDA UNII
LQ54E5B4EW

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[3-[4-[4-(cyclohexylmethylsulfonylamino)butyl]piperazin-1-yl]phenyl]acetamide
2.1.2 InChI
InChI=1S/C23H38N4O3S/c1-20(28)25-22-10-7-11-23(18-22)27-16-14-26(15-17-27)13-6-5-12-24-31(29,30)19-21-8-3-2-4-9-21/h7,10-11,18,21,24H,2-6,8-9,12-17,19H2,1H3,(H,25,28)
2.1.3 InChI Key
SPWZXWDPAWDKQE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(=O)NC1=CC(=CC=C1)N2CCN(CC2)CCCCNS(=O)(=O)CC3CCCCC3
2.2 Other Identifiers
2.2.1 UNII
LQ54E5B4EW
2.3 Synonyms
2.3.1 MeSH Synonyms

1. N-(3-(4-(4-cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl)phenyl)acetamide

2. Prx 00023

3. Prx-00023

4. Prx00023

2.3.2 Depositor-Supplied Synonyms

1. 740873-06-7

2. Prx-00023

3. Naluzotan (free Base)

4. Lq54e5b4ew

5. Chembl209821

6. Unii-lq54e5b4ew

7. Acetamide, N-(3-(4-(4-(((cyclohexylmethyl)sulfonyl)amino)butyl)-1-piperazinyl)phenyl)-

8. N-(3-(4-(4-(((cyclohexylmethyl)sulfonyl)amino)butyl)piperazin-1-yl)phenyl)acetamide

9. N-(3-(4-(4-((cyclohexylmethyl)sulfonamido)butyl)piperazin-1-yl)phenyl)acetamide

10. Naluzotan [usan]

11. Naluzotan [usan:inn]

12. N-(3-(4-(4-cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl)phenyl)acetamide

13. N-(3-[4-(4-cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl]phenyl)acetamide

14. N-[3-[4-[4-(cyclohexylmethylsulfonylamino)butyl]piperazin-1-yl]phenyl]acetamide

15. Prx 00023

16. Naluzotan [inn]

17. Naluzotan (usan/inn)

18. Schembl678016

19. Dtxsid40995527

20. Bcp20177

21. Prx00023

22. Zinc3963096

23. Bdbm50187377

24. Cs-6740

25. Db05562

26. Sb16847

27. Hy-14848

28. Db-115004

29. D09358

30. 833c676

31. L001689

32. Q6961039

33. N-(3-(4-(4-(cyclohexylmethylsulfonamido)butyl)piperazin-1-yl)phenyl)acetamide

34. N-[3-[4-[4-[(cyclohexylmethylsulfonyl)amino]butyl]piperazin-1-yl]phenyl]acetamide

35. N-{3-[4-(4-cyclohexylmethanesulfonylamino-butyl)-piperazin-1-yl]-phenyl}-acetamide

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 450.6 g/mol
Molecular Formula C23H38N4O3S
XLogP33.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count10
Exact Mass450.26646226 g/mol
Monoisotopic Mass450.26646226 g/mol
Topological Polar Surface Area90.1 Ų
Heavy Atom Count31
Formal Charge0
Complexity638
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in anxiety disorders and depression.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Serotonin 5-HT1 Receptor Agonists

Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes. (See all compounds classified as Serotonin 5-HT1 Receptor Agonists.)